Fundraising Fox

Wavegate

Lake Charles, US · Founded 2025 · Delaware corporation

Wavegate develops the Ellipse™ platform, an implantable bioadaptive electroceutical system that combines multi-modal physiologic sensing (optical reflectometry, evoked potentials, hemodynamics, ECG, and motion) with AI-based state estimation and adaptive control to deliver closed-loop neuromodulation therapy, starting with spinal cord stimulation for chronic pain. The company targets clinicians and researchers in neuromodulation, with all programs currently investigational and not FDA-approved.

AI & Machine LearningHealthtechMedical Devices

Founders & leadership

MA
Marla A. MillerinExecutive
EW
Erich Wolf, IINamed on SEC filing
RJ
Russell J. Stutes, Jr.Named on SEC filing
RE
Robert E EhlersNamed on SEC filing
DP
Dennis Patrick O'NealNamed on SEC filing

Board

MT
Matthew ThomasBoard director
AWAshley Wade
Ashley WadeBoard director
DPD. Patrick O'Neal
D. Patrick O'NealBoard director

Reported raises · per SEC filings

Form D private placements

$5.2M disclosed across 2 rounds · 2020–2025

▶$2.8MraisedJun 2025 · 38 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Erich Wolf, IIExecutive Officer, Director
  • Matthew ThomasDirector
  • Ashley WadeDirector
  • D. Patrick O'NealDirector
  • Marla A. MillerExecutive Officer
Offering amount
$28.7M
Amount sold
$2.8M
First sale
Mar 2025
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.4MraisedMar 2023 · 38 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ashley WadeDirector
  • Marla A MillerExecutive Officer
  • Russell J. Stutes, Jr.Executive Officer
  • Robert E EhlersExecutive Officer
  • Dennis Patrick O'NealDirector
  • Erich William Wolf, IIExecutive Officer, Director
Offering amount
$10M
Amount sold
$2.4M
Minimum investment
$25K
First sale
May 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Cedar Gate Technologies3 shared keywordsCedargate provides a unified software platform for healthcare organizations transitioning to value-based care models, with integrated data management, analytics, decision support, and claims processing tools. The platform helps providers measure outcomes, reduce costs, and coordinate care delivery across multiple payer and patient populations.

Companies competing with Wavegate for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Wavegate Secures $26M to Advance Neuromodulation Technology for Chronic Painhlth.com · Dec 2024Wavegate: Neuromodulation Technology Company Reveals $26 Million (Series A) Roundpulse2.com · Dec 2024Wavegate Corporation Raises $26M in Series A Fundingfinsmes.com · Dec 2024Wavegate Corporation Announces $26 Million Series A Funding Round Led by UCEA Capital Partners Ltd.prnewswire.com · Dec 2024Wavegate Corporation | MobiHealthNewsmobihealthnews.com

Frequently asked questions

What does Wavegate do?
Wavegate develops the Ellipse™ platform, an implantable bioadaptive electroceutical system that combines multi-modal physiologic sensing (optical reflectometry, evoked potentials, hemodynamics, ECG, and motion) with AI-based state estimation and adaptive control to deliver closed-loop neuromodulation therapy, starting with spinal cord stimulation for chronic pain. The company targets clinicians and researchers in neuromodulation, with all programs currently investigational and not FDA-approved.
How much funding has Wavegate raised?
Wavegate has disclosed $5.2M raised across 2 rounds.
Where is Wavegate headquartered?
Wavegate is headquartered in Lake Charles, US.